Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients.
Solid is headquartered in Charlestown, MA, USA.
|
|
|
51-200 employees
View all Solid Biosciences employees
|
|
Biotechnology
|
|
500 Rutherford Ave, Third Floor, Boston, Massachusetts 02129, US
|
|
2013
|
|
Biotechnology, Biotechnology Research, Duchenne Muscular Dystrophy
|
Bo Cumbo is the CEO of Solid Biosciences. To contact Bo Cumbo email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.